Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine.
about
Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.Establishment of a Model of Microencapsulated SGC7901 Human Gastric Carcinoma Cells Cocultured with Tumor-Associated Macrophages.Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer
P2860
Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Mitochondrial biomarkers predi ...... ics for personalized medicine.
@en
type
label
Mitochondrial biomarkers predi ...... ics for personalized medicine.
@en
prefLabel
Mitochondrial biomarkers predi ...... ics for personalized medicine.
@en
P2860
P356
P1433
P1476
Mitochondrial biomarkers predi ...... ics for personalized medicine.
@en
P2860
P304
67117-67128
P356
10.18632/ONCOTARGET.19962
P407
P577
2017-08-05T00:00:00Z